SYNZYME TECHNOLOGY, INC.

Basic Information

1 TECHNOLOGY DR, B-115
IRVINE, CA, 92618-

Company Profile

n/a

Additional Details

Field Value
DUNS: 36552925
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Polynitroxylated Pegylated Hemoglobin for Traumatic Brian Injury Resuscitation

    Amount: $2,900,675.00

    DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension. Vulnerability of T ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. Polynitroxylated Pegylated Hemoglobin for Traumatic Brian Injury Resuscitation

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension. Vulnerability of T ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. STROMA-FREE HEMOGLOBIN and HBOC PRODUCTION

    Amount: $100,037.00

    N/A

    SBIR Phase I 2008 Department of Health and Human Services
  4. PNA for Stroke

    Amount: $2,928,858.00

    DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death in the U.S. and is also a leading cause of severe, long-term disability. The total cost of stroke to the United States is ...

    SBIR Phase II 2005 Department of Health and Human Services
  5. TOPS-Ester: Pharmacokinetics and Imaging in Human Skin

    Amount: $100,003.00

    DESCRIPTION (provided by applicant): TOPS-ester is a topical drug selected for development for it's unique ability to compartmentalize within skin cells and express antioxidant activity that limits ox ...

    SBIR Phase I 2003 Department of Health and Human Services
  6. Brain Injury During CPR Prevented by Vascular Nitroxide

    Amount: $100,004.00

    DESCRIPTION (provided by applicant): The brain damage that frequently accompanies cardiac arrest and resuscitation is devastating. Fewer than 10% of cardiopulmonary resuscitation (CPR) attempts resul ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. TOPS-ESTER MODULATION OF UVB-INDUCED IMMUNE SUPPRESSION

    Amount: $98,736.00

    DESCRIPTION (provided by applicant): A TOPS-ester, diethyl 2,2,6,6-tetramethyl-1-oxyl-4-piperidene succinate (DETOPS), is a topical drug selected for development for its unique ability to compartment ...

    SBIR Phase I 2002 Department of Health and Human Services
  8. POLYNITROXYL HEMOGLOBIN:NEUROPROTECTIVE OXYGEN CARRIER

    Amount: $100,044.00

    DESCRIPTION: (Investigator's abstract) Polynitroxyl hemoglobin (PNH) will be developed as a neuroprotective oxygen carrier. PNH is different from 1st generation hemoglobin-based ox ...

    SBIR Phase I 2001 Department of Health and Human Services
  9. NITROXIDE THERAPY FOR INFLAMMATORY BOWEL DISEASE

    Amount: $100,000.00

    DESCRIPTION (Adapted from the application): Free radicals play important roles in inflammatory bowel disease (IBD), and the reduction or elimination of the adverse effects of these oxida ...

    SBIR Phase I 2001 Department of Health and Human Services
  10. N/A

    Amount: $100,000.00

    Not Available Aspen Systems proposes to develop new Ultra-High Temperature Resistant Aerogels that will withstand temperatures as high as 2300 K for long periods of time. The new insulation will be ba ...

    SBIR Phase I 2000 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government